Table 4.
Dynamics of clinical pattern of the wound healing in the animals with the wounds infected with S. aureus 592 (M ± m).
| Subgroup | Clinical Presentation | |||
|---|---|---|---|---|
| Disappearance of Perifocal Oedema, Days | Full Wound Cleansing, Days | Appearance of Granulation, Days | Start of edge Epithelialisation, Days | |
| Placebo | 9.29 ± 0.18 | 10.29 ± 0.18 | 10.43 ± 0.20 | 10.86 ± 0.14 |
| Control | 7.00 ± 0.32 * | 8.20 ± 0.20 * | 8.20 ± 0.20 * | 8.20 ± 0.20 * |
| Resveratrol | 7.43 ± 0.20 * | 8.14 ± 0.14 * | 8.14 ± 0.14 * | 8.14 ± 0.14 * |
| Dihydroquercetin | 8.00 ± 0.00 *,# | 8.60 ± 0.24 * | 8.20 ± 0.20 * | 8.20 ± 0.20 * |
| Dihydromyricetin | 7.29 ± 0.18 * | 8.57 ± 0.2 * | 8.14 ± 0.14 * | 8.14 ± 0.14 * |
*—p < 0.05 if being compared to the placebo group, #—p < 0.05 if being compared to the control group.